• Deutsch
  • Home
  • Search
  • Browse
  • Publish
  • Help
Schließen
  • Faculties
  • Medizinische Fakultät

Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I)

Refine

Has Fulltext

  • yes (437)

Is part of the Bibliography

  • yes (437)

Year of publication

  • 2022 (10)
  • 2021 (51)
  • 2020 (38)
  • 2019 (21)
  • 2018 (16)
  • 2017 (10)
  • 2016 (12)
  • 2015 (13)
  • 2014 (15)
  • 2013 (11)
+ more

Document Type

  • Doctoral Thesis (243)
  • Journal article (179)
  • Conference Proceeding (12)
  • Habilitation (1)
  • Master Thesis (1)
  • Other (1)

Language

  • German (257)
  • English (180)

Keywords

  • Chirurgie (30)
  • Medizin (9)
  • Transplantation (9)
  • Dickdarmkrebs (8)
  • Immunbiologie (8)
  • Langerhans-Inseln (8)
  • Rezidiv (7)
  • colorectal cancer (7)
  • cytokines (7)
  • obesity (7)
+ more

Author

  • Ulrichs, Karin (68)
  • Müller-Ruchholtz, W. (46)
  • Germer, Christoph-Thomas (38)
  • Wiegering, Armin (29)
  • Otto, Christoph (19)
  • Schlegel, Nicolas (18)
  • Eckstein, V. (13)
  • Heiser, A. (13)
  • Baur, Johannes (10)
  • Gasser, Martin (9)
+ more

Institute

  • Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (437)
  • Theodor-Boveri-Institut für Biowissenschaften (24)
  • Medizinische Klinik und Poliklinik II (15)
  • Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (13)
  • Klinik und Poliklinik für Anästhesiologie (ab 2004) (12)
  • Pathologisches Institut (10)
  • Medizinische Klinik und Poliklinik I (9)
  • Kinderklinik und Poliklinik (8)
  • Frauenklinik und Poliklinik (6)
  • Comprehensive Cancer Center Mainfranken (5)
+ more

Sonstige beteiligte Institutionen

  • Abteilung für Molekulare Onkoimmunologie (1)
  • Comprehensive Cancer Center Mainfranken an der Universität Würzburg (1)
  • Comprehensive Cancer Center Mainfranken, University of Wuerzburg, Wuerzburg, Germany (1)
  • Comprehensive Cancer Centre Mainfranken, University Hospital, University of Wuerzburg, Josef-Schneiderstr. 6, 97080 Wuerzburg, Germany (1)
  • Harvard Medical School, Boston, USA (1)
  • Institut für Medizinische Lehre und Ausbildungsforschung, Universität Würzburg (1)
  • Klinikum Fulda (1)
  • Klinikum Main-Spessart Lohr (1)
  • Krankenhaushygiene und Antimicrobial Stewardship (1)
  • Lehrkrankenhaus der Universität Würzburg: Klinikum Main-Spessart (1)
+ more

EU-Project number / Contract (GA) number

  • 241592 (1)
  • 678119 (1)

437 search hits

  • 1 to 10
  • BibTeX
  • CSV
  • RIS
  • XML
  • 10
  • 20
  • 50
  • 100

Sort by

  • Year
  • Year
  • Title
  • Title
  • Author
  • Author
Leaky gut as a potential culprit for the paradoxical dysglycemic response to gastric bypass-associated ileal microbiota (2021)
Hankir, Mohammed K. ; Seyfried, Florian ; Schellinger, Isabel N. ; Schlegel, Nicolas ; Arora, Tulika
Altered host-intestinal microbiota interactions are increasingly implicated in the metabolic benefits of Roux-en-Y gastric bypass (RYGB) surgery. We previously found, however, that RYGB-associated ileal microbiota can paradoxically impair host glycemic control when transferred to germ-free mice. Here we present complementary evidence suggesting that this could be due to the heightened development of systemic endotoxemia. Consistently, application of ileal content from RYGB-treated compared with sham-operated rats onto Caco-2 cell monolayers compromised barrier function and decreased expression of the barrier-stabilizing proteins claudin-4 and desmoglein-2. Our findings raise the possibility that RYGB-associated ileal microbiota produce and release soluble metabolites which locally increase intestinal permeability to promote systemic endotoxemia-induced insulin resistance, with potential implications for the treatment of RYGB patients who eventually relapse onto type 2 diabetes.
Development of a simple and robust whole blood assay with dual co-stimulation to quantify the release of T-cellular signature cytokines in response to Aspergillus fumigatus antigens (2021)
Lauruschkat, Chris D. ; Page, Lukas ; White, P. Lewis ; Etter, Sonja ; Davies, Helen E. ; Duckers, Jamie ; Ebel, Frank ; Schnack, Elisabeth ; Backx, Matthijs ; Dragan, Mariola ; Schlegel, Nicolas ; Kniemeyer, Olaf ; Brakhage, Axel A. ; Einsele, Hermann ; Loeffler, Juergen ; Wurster, Sebastian
Deeper understanding of mold-induced cytokine signatures could promote advances in the diagnosis and treatment of invasive mycoses and mold-associated hypersensitivity syndromes. Currently, most T-cellular immunoassays in medical mycology require the isolation of mononuclear cells and have limited robustness and practicability, hampering their broader applicability in clinical practice. Therefore, we developed a simple, cost-efficient whole blood (WB) assay with dual α-CD28 and α-CD49d co-stimulation to quantify cytokine secretion in response to Aspergillus fumigatus antigens. Dual co-stimulation strongly enhanced A. fumigatus-induced release of T-cellular signature cytokines detectable by enzyme-linked immunosorbent assay (ELISA) or a multiplex cytokine assay. Furthermore, T-cell-dependent activation and cytokine response of innate immune cells was captured by the assay. The protocol consistently showed little technical variation and high robustness to pre-analytic delays of up to 8 h. Stimulation with an A. fumigatus lysate elicited at least 7-fold greater median concentrations of key T-helper cell signature cytokines, including IL-17 and the type 2 T-helper cell cytokines IL-4 and IL-5 in WB samples from patients with Aspergillus-associated lung pathologies versus patients with non-mold-related lung diseases, suggesting high discriminatory power of the assay. These results position WB-ELISA with dual co-stimulation as a simple, accurate, and robust immunoassay for translational applications, encouraging further evaluation as a platform to monitor host immunity to opportunistic pathogens.
Leptin improves parameters of brown adipose tissue thermogenesis in lipodystrophic mice (2021)
Hoffmann, Annett ; Ebert, Thomas ; Hankir, Mohammed K. ; Flehmig, Gesine ; Klöting, Nora ; Jessnitzer, Beate ; Lössner, Ulrike ; Stumvoll, Michael ; Blüher, Matthias ; Fasshauer, Mathias ; Tönjes, Anke ; Miehle, Konstanze ; Kralisch, Susan
Lipodystrophy syndromes (LD) are a heterogeneous group of very rare congenital or acquired disorders characterized by a generalized or partial lack of adipose tissue. They are strongly associated with severe metabolic dysfunction due to ectopic fat accumulation in the liver and other organs and the dysregulation of several key adipokines, including leptin. Treatment with leptin or its analogues is therefore sufficient to reverse some of the metabolic symptoms of LD in patients and in mouse models through distinct mechanisms. Brown adipose tissue (BAT) thermogenesis has emerged as an important regulator of systemic metabolism in rodents and in humans, but it is poorly understood how leptin impacts BAT in LD. Here, we show in transgenic C57Bl/6 mice overexpressing sterol regulatory element-binding protein 1c in adipose tissue (Tg (aP2-nSREBP1c)), an established model of congenital LD, that daily subcutaneous administration of 3 mg/kg leptin for 6 to 8 weeks increases body temperature without affecting food intake or body weight. This is associated with increased protein expression of the thermogenic molecule uncoupling protein 1 (UCP1) and the sympathetic nerve marker tyrosine hydroxylase (TH) in BAT. These findings suggest that leptin treatment in LD stimulates BAT thermogenesis through sympathetic nerves, which might contribute to some of its metabolic benefits by providing a healthy reservoir for excess circulating nutrients.
Leptin receptors are not required for Roux-en-Y gastric bypass surgery to normalize energy and glucose homeostasis in rats (2021)
Hankir, Mohammed K. ; Rotzinger, Laura ; Nordbeck, Arno ; Corteville, Caroline ; Dischinger, Ulrich ; Knop, Juna-Lisa ; Hoffmann, Annett ; Otto, Christoph ; Seyfried, Florian
Sensitization to the adipokine leptin is a promising therapeutic strategy against obesity and its comorbidities and has been proposed to contribute to the lasting metabolic benefits of Roux-en-Y gastric bypass (RYGB) surgery. We formally tested this idea using Zucker fatty fa/fa rats as an established genetic model of obesity, glucose intolerance, and fatty liver due to leptin receptor deficiency. We show that the changes in body weight in these rats following RYGB largely overlaps with that of diet-induced obese Wistar rats with intact leptin receptors. Further, food intake and oral glucose tolerance were normalized in RYGB-treated Zucker fatty fa/fa rats to the levels of lean Zucker fatty fa/+ controls, in association with increased glucagon-like peptide 1 (GLP-1) and insulin release. In contrast, while fatty liver was also normalized in RYGB-treated Zucker fatty fa/fa rats, their circulating levels of the liver enzyme alanine aminotransferase (ALT) remained elevated at the level of obese Zucker fatty fa/fa controls. These findings suggest that the leptin system is not required for the normalization of energy and glucose homeostasis associated with RYGB, but that its potential contribution to the improvements in liver health postoperatively merits further investigation.
Bedeutung der Expression von MMP-1 und MMP-13 beim Barrett assoziierten Adenokarzinom (2022)
Zeeb, Luisa
Es wird vermutet, dass das ösophageale Adenokarzinom (EAC) durch gastroosophagealen Reflux auf dem Boden des Barrett-Ösophagus (BE) entsteht. Bei der Tumorprogression könnten Matrix-Metalloproteasen eine wichtige Rolle spielen. Die Expression von MMP-1 und MMP-13 wurde im Ösophaguskarziom (n=41 EAC mit BE, n=19 EAC ohne BE, n=10 Plattenepithelkarzinom, ESCC) sowie im nicht-dysplastischen BE (n=18) untersucht. Die Koexpression von MMP-1 und Cdx-2 (intestinale Metaplasie) und die Koexpression von MMP-1 und Ki-67 (Proliferation) wurde mittels Immunhistochemie und auf mRNA-Ebene untersucht. Die Ergebnisse wurde mit klinisch-pathologischen Eigenschaften korreliert. Im gesunden Plattenepithel wurde weder MMP-1 noch MMP-13 exprimiert. In allen EAC ohne BE wurde MMP-1 exprimiert (100%). Im EAC mit BE, war in 95% MMP-1 im EAC nachweisbar. Die Expression von MMP-1 im BE ohne IN lag bei 56%. Das ESCC exprimierte in 60% MMP-1. Bei der quantitativen Analyse zeigten sich 48% MMP-1 positive Zellen im EAC mit BE und 35% im angrenzendem BE (p<0,05). Mit 44% MMP-1 positiver Zellen im EAC ohne BE, lag die Expression signifikant über der im BE mit EAC (p<0,05). Im ESCC (32% MMP-1 positiv) lag eine im Vergleich zu allen EACs signifikant geringere Expression vor. Im BE ohne IN waren 4% der Zellen MMP-1 positiv. Die RT-PCR bestätigte die Ergebnisse der IHC auf mRNA-Ebene. Eine Präparate waren negativ für MMP-13. Die Untersuchung der Koexpression von MMP-1 in Ki-67 positiven Zellen zeigte eine starke direkte Korrelation (r=0,943 für BE und r= 0,811 für EAC). Eine hohe MMP-1 Expression war mit einem positiven Lymphknotenstatus assoziiert aber nicht mit einem schlechterem Überleben (p=0,307). Die Ergebnisse zeigen, dass MMP-1 eine wichtige Rolle bei der Invasion und Metastasierung des Barrett assoziierten EAC spielen könnte. Die Assoziation eines positiven Lymphknotenstatus mit hoher MMP-1-Expression spricht dafür, dass MMP-1 ein wichtiger Faktor bei der malignen Progression sein könnte.
Brain metastases from colorectal cancer: a systematic review of the literature and meta-analysis to establish a guideline for daily treatment (2021)
Müller, Sophie ; Köhler, Franziska ; Hendricks, Anne ; Kastner, Carolin ; Börner, Kevin ; Diers, Johannes ; Lock, Johan F. ; Petritsch, Bernhard ; Germer, Christoph-Thomas ; Wiegering, Armin
Colorectal cancer (CRC) is the third most common malignancy worldwide. Most patients with metastatic CRC develop liver or lung metastases, while a minority suffer from brain metastases. There is little information available regarding the presentation, treatment, and overall survival of brain metastases (BM) from CRC. This systematic review and meta-analysis includes data collected from three major databases (PubMed, Cochrane, and Embase) based on the key words “brain”, “metastas*”, “tumor”, “colorectal”, “cancer”, and “malignancy”. In total, 1318 articles were identified in the search and 86 studies matched the inclusion criteria. The incidence of BM varied between 0.1% and 11.5%. Most patients developed metastases at other sites prior to developing BM. Lung metastases and KRAS mutations were described as risk factors for additional BM. Patients with BM suffered from various symptoms, but up to 96.8% of BM patients were asymptomatic at the time of BM diagnosis. Median survival time ranged from 2 to 9.6 months, and overall survival (OS) increased up to 41.1 months in patients on a multimodal therapy regimen. Several factors including age, blood levels of carcinoembryonic antigen (CEA), multiple metastases sites, number of brain lesions, and presence of the KRAS mutation were predictors of OS. For BM diagnosis, MRI was considered to be state of the art. Treatment consisted of a combination of surgery, radiation, or systemic treatment.
Einfluss der minimalen Distanz zwischen Tumor und Resektatrand auf die Prognose kurativ resezierter Patienten mit hepatocellulärem Carcinom (2022)
Döring, Anna Maria
Dies ist eine retrospektive unizentrische Analyse um den Einfluss des Resektionsabstandes auf prognostische Faktoren wie das rezidivfreie und Gesamtüberleben bei Patienten mit hepatocellulären Carcinom zu untersuchen. Es ließ sich kein Vorteil eines weiten (>5mm) tumorfreien Abstands zum Resektatrand gegenüber einem schmalen (5mm) tumorfreien Abstand nachweisen. Allerdings wurden andere tumor- und patientenspezifische unabhängige Risikofaktoren für das rezidivfreie und Gesamtüberleben identifiziert. So ist ein präoperativer AFP-Wert >15µg/l mit einem signifikant schlechteren krankheitsfreien und Gesamtüberleben assoziiert. Ebenso haben schlecht differenzierte (G3) HCCs, sowie HCC mit einer vaskulären Invasion (V1/V2) ein deutlich reduziertes rezidivfreies Überleben. Auch eine Tumorgröße >5cm war in dieser Studie ein unabhängiger Risikofaktor für ein verkürztes Gesamtüberleben.
Defining the scope of antimicrobial stewardship interventions on the prescription quality of antibiotics for surgical intra-abdominal infections (2021)
Surat, Güzin ; Vogel, Ulrich ; Wiegering, Armin ; Germer, Christoph-Thomas ; Lock, Johan Friso
Background: The aim of this study was to assess the impact of antimicrobial stewardship interventions on surgical antibiotic prescription behavior in the management of non-elective surgical intra-abdominal infections, focusing on postoperative antibiotic use, including the appropriateness of indications. Methods: A single-center quality improvement study with retrospective evaluation of the impact of antimicrobial stewardship measures on optimizing antibacterial use in intra-abdominal infections requiring emergency surgery was performed. The study was conducted in a tertiary hospital in Germany from January 1, 2016, to January 30, 2020, three years after putting a set of antimicrobial stewardship standards into effect. Results: 767 patients were analyzed (n = 495 in 2016 and 2017, the baseline period; n = 272 in 2018, the antimicrobial stewardship period). The total days of therapy per 100 patient days declined from 47.0 to 42.2 days (p = 0.035). The rate of patients receiving postoperative therapy decreased from 56.8% to 45.2% (p = 0.002), comparing both periods. There was a significant decline in the rate of inappropriate indications (17.4% to 8.1 %, p = 0.015) as well as a significant change from broad-spectrum to narrow-spectrum antibiotic use (28.8% to 6.5%, p ≤ 0.001) for postoperative therapy. The significant decline in antibiotic use did not affect either clinical outcomes or the rate of postoperative wound complications. Conclusions: Postoperative antibiotic use for intra-abdominal infections could be significantly reduced by antimicrobial stewardship interventions. The identification of inappropriate indications remains a key target for antimicrobial stewardship programs.
Einfluss der präoperativen Konditionierung mittels Magenballon vor bariatrischer Operation auf den Therapieerfolg bei extremer Adipositas – Eine retrospektive Vergleichsstudie (2022)
Dörries, Luise
Die Adipositaschirurgie ist die effektivste Methode in der Behandlung der Adipositas. Bei extrem adipösen Patientin ist eine primäre Operation oftmals riskant. Die Anlage eines Magenballons als erster Schritt von Mehrstufenkonzepten kann die Operabilität gewährleisten und die perioperative Sicherheit erhöhen. Durch den Magenballon wird ein signifikanter Gewichtsverlust erreicht. Der postoperative Gewichtsverlust fällt allerdings schwächer aus. Es ist wichtig, den Patienten realistische Therapieergebnisse zu vermitteln, um überhöhte Erwartungen und Unzufriedenheit zu vermeiden. Die Sleevegastrektomie eignet sich besonders für extrem adipöse Patienten, da diese eine geringere Komplikationsrate aufweist und einfach in einen Roux-en-Y Bypass umzuwandeln ist.
Successful surgical closure of infected abdominal wounds following preconditioning with negative pressure wound therapy (2021)
Wagner, Johanna C. ; Wetz, Anja ; Wiegering, Armin ; Lock, Johan F. ; Löb, Stefan ; Germer, Christoph-Thomas ; Klein, Ingo
Purpose Traditionally, previous wound infection was considered a contraindication to secondary skin closure; however, several case reports describe successful secondary wound closure of wounds "preconditioned" with negative pressure wound therapy (NPWT). Although this has been increasingly applied in daily practice, a systematic analysis of its feasibility has not been published thus far. The aim of this study was to evaluate secondary skin closure in previously infected abdominal wounds following treatment with NPWT. Methods Single-center retrospective analysis of patients with infected abdominal wounds treated with NPWT followed by either secondary skin closure referenced to a group receiving open wound therapy. Endpoints were wound closure rate, wound complications (such as recurrent infection or hernia), and perioperative data (such as duration of NPWT or hospitalization parameters). Results One hundred ninety-eight patients during 2013-2016 received a secondary skin closure after NPWT and were analyzed and referenced to 67 patients in the same period with open wound treatment after NPWT. No significant difference in BMI, chronic immunosuppressive medication, or tobacco use was found between both groups. The mean duration of hospital stay was 30 days with a comparable duration in both patient groups (29 versus 33 days, p = 0.35). Interestingly, only 7.7% of patients after secondary skin closure developed recurrent surgical site infection and in over 80% of patients were discharged with closed wounds requiring only minimal outpatient wound care. Conclusion Surgical skin closure following NPWT of infected abdominal wounds is a good and safe alternative to open wound treatment. It prevents lengthy outpatient wound therapy and is expected to result in a higher quality of life for patients and reduce health care costs.
  • 1 to 10

DINI-Zertifikat     OPUS4 Logo

  • Contact
  • |
  • Imprint
  • |
  • Sitemap